Vial is a next-generation, technology-first contract research organization (CRO) that operates in multiple therapeutic areas including dermatology.

Ankit Agarwal  is Vial’s  new VP of Operations. 

Vial is a next-generation, technology-first contract research organization (CRO) that operates in multiple therapeutic areas including dermatology.

Mr. Agarwal joins the team with more than 10 years of experience in strategy and operations. He has worked in both large multinational and startup environments, helping create and implement strategies to scale businesses and increase profitability. Mr. Agarwal has served as an operations leader in his last two roles, where he led multidisciplinary teams to deliver operational excellence and achieve business goals.

 "I'm extremely excited to join Vial because we are making a real difference for our clients and consumers by improving the speed and quality of clinical trials. Running operations at a rapidly growing organization, such as Vial, is both challenging and rewarding, with the need to balance structure with flexibility and speed. I'm looking forward to helping build an operationally excellent, robust, and tech-driven organization that is ready to meet the current and future needs of the business," says Mr. Agarwal in a news release.

Agarwal is set to collaborate with Vial's leadership team to strategize, manage, synchronize, and supervise the company's operations.

"Vial is building towards a more efficient future for clinical trials. By deploying technology at every step, we are driving efficiencies in speed and cost savings for innovative biotech companies of all sizes. We are excited to have Ankit join our team and help us in this mission," says Simon Burns, CEO and CO-Founder of Vial.